openPR Logo
Press release

Human Immunodeficiency Virus Therapeutics Market set to increase significantly by 2025

07-14-2017 04:15 PM CET | Health & Medicine

Press release from: TMR Research

Human Immunodeficiency Virus Therapeutics Market set

Global Human Immunodeficiency Virus Therapeutics Market: Overview

AIDS is perhaps the greatest threat posed by infectious diseases to human health in history. As this disease remains incurable at the moment, the development of anti- HIV therapies is crucial to slow down the progression of the virus. Therefore, the global market for HIV therapeutics will witness tremendous growth during the forthcoming period.

Almost 36.7 million people were suffering from this deadly disease towards the end of 2015, according to the findings of World Health Organization (WHO). As the incidence of AIDS is not likely to reduce anytime soon, the global HIV therapeutics market is expected to exhibit a positive trajectory in the forthcoming years

The report by Transparency Market Research (TMR) discusses the trends, catalysts, opportunities, and deterrents of the global human immunodeficiency virus therapeutics market. The major vendors are studies in-depth, wherein their key business strategies, market shares, and product portfolios have been discussed. The market attractiveness, competitive landscape, market projections, supply and demand dynamics, and value chain analysis have also been revealed along with relevant statistical data.

Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1187

Global Human Immunodeficiency Virus Therapeutics Market: Drivers and Restraints

The increasing prevalence of HIV infections, particularly amongst the youth worldwide owing to unprotected sexual activities, lack of awareness about the risk of transmission, and the usage of contaminated needles and syringes have been the most prominent growth drivers boosting the global HIV therapeutics market. The growing healthcare expenditures of governments and the gradual spread of awareness about the availability of anti-HIV therapies are also contributing towards market growth.

Research conducted in novel scientific arenas such as pharmacogenetics and pharmacogenomics have been backing up the expansion of the market. The most awaited advent of personalized treatments wherein medications are optimized for every single patient considering the individual's genetic makeup has raised the hopes of HIV positive patients. Several community groups, national research groups, regulatory bodies, pharmaceutical companies and patients have joined forces against HIV, working towards the development of effective HIV therapies. All this has triggered the growth of the global HIV therapeutics market. Moreover, as several drugs are constantly being developed and are entering clinical investigation each day, it is likely that they will be easily available in near future, promoting the expansion of the market substantially.

Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1187

Global Human Immunodeficiency Virus Therapeutics Market: Regional Outlook

On the basis of geography, the global human immunodeficiency virus therapeutics market can be segmented into Latin America, Europe, Asia Pacific, the Middle East and Africa, and North America.

Escalating incidence of this infection has been observed in Russia, Latin America, and several parts of Caribbean. Therefore, these regions are expected to display considerable demand over the coming period. The continents of Asia and Africa are plagued by this viral infection, with countries such as China, India, and Nigeria with high incidence of HIV infections. According to the WHO, 1 out of 25 people are suffering from HIV infection in the Sub-Saharan Africa, making up almost 70% of the entire global HIV population.

Steps taken by governments to improve access to HIV therapies in these emerging economies are likely to boost the demand for HIV therapeutics in these regions. Moreover, numerous national and international initiatives across the globe by institutions such as the HIVNAT (The Netherlands, Australia, and Thailand) Network, Harvard AIDS Institute, and MSF (Médecins Sans Frontières) have also been guiding growth.

Read Comprehensive Overview of Report@ https://www.tmrresearch.com/human-immunodeficiency-virus-therapeutics-market

Companies Mentioned in the Report

Some of the major companies operating in the global human immunodeficiency virus therapeutics market are ViiV Healthcare, Boehringer Ingelheim GmbH, Merck & Co., Cipla, Inc., Bristol-Myers Squibb Company, and AbbVie, Inc.

About TMR Research :

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

Rohit Bhisey
Head - Internet Marketing
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Immunodeficiency Virus Therapeutics Market set to increase significantly by 2025 here

News-ID: 624887 • Views: 104

More Releases from TMR Research

Crowd Analytics Market Regional Analysis by 2025 | Nokia Corporation, AGT Intern …
Crowd Analytics Market: Snapshot The global crowd analytics market is driven by growing security threats. The heightened demand for intelligence video systems and a need for business intelligence systems will also drive the crowd analytics market in the period from 2017 to 2025. This market is anticipated to witness a rapid rise due to the heightened need for business intelligence solutions on account of which there is a high demand from
Cloud Orchestration Market Trends and Dynamic Demand by 2025 | IBM Corporation, …
Cloud Orchestration Market: Snapshot Cloud orchestration is the arrangement and coordination of automated tasks and results finally in a process or workflow that is consolidated. The rising demand for optimum utilization of resources is anticipated to drive the global cloud orchestration market. The increasing need for self-service provisioning, agility, and flexibility will also be key factors resulting the growth of this market worldwide. In addition to this, the cost efficiency of
C4ISR Market Witness High Demand During by 2025 | Northrop Grumman, Bae Systems, …
Global C4ISR Market: Snapshot The global C4ISR market has been displaying immense growth potential over the past few years, thanks to the integration of C41SR systems in the existing platforms, including as land-based, naval, space, and airborne platforms. As the deployment of these systems ensures faster operations at reduced costs, a robust increase in their uptake has been observed across all the platforms. Several technological advancements in the global C4ISR market,
Emergency Management and Incident Management Market Analysis and Forecast 2025
Global Emergency Management and Incident Management Market: Snapshot The global emergency management and incident management market is expected to see the increased integration of machine-to-machine (M2M) communication technologies and sensors in new-age devices. The capability of new-generation sensing technologies to provide real-time analysis and management of risks related to natural and premeditated risks is expected to compel government bodies to replace ageing and obsolete technologies with the ones with smart sensing

All 5 Releases


More Releases for HIV

Global HIV Market to 2024
The HIV market was valued at $16bn in 2015 and is forecast to expand at a CAGR of 3.7% between 2015 and 2024, culminating in 2024 global sales of $23bn.The expected arrival of new classes of therapies could result in a paradigm shift in the treatment of HIV treatment. Globally, around 35 million people are infected with HIV. Approximately 3 million people in the U.S and 2.5 million in top 5
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Global HIV Infection Pipeline Analysis
The discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retrovirals in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have
Global HIV Therapeutics Market
The HIV Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral